Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/AVN-101> ?p ?o }
Showing triples 1 to 44 of
44
with 100 triples per page.
- AVN-101 abstract "AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.".
- AVN-101 wikiPageExternalLink 800030006.
- AVN-101 wikiPageExternalLink cns-platform.
- AVN-101 wikiPageExternalLink pipeline.
- AVN-101 wikiPageID "46946260".
- AVN-101 wikiPageLength "3171".
- AVN-101 wikiPageOutDegree "13".
- AVN-101 wikiPageRevisionID "698190712".
- AVN-101 wikiPageWikiLink 5-HT6_receptor.
- AVN-101 wikiPageWikiLink AVN-211.
- AVN-101 wikiPageWikiLink Alzheimers_disease.
- AVN-101 wikiPageWikiLink Anxiety_disorder.
- AVN-101 wikiPageWikiLink Avineuro_Pharmaceuticals.
- AVN-101 wikiPageWikiLink Category:5-HT6_antagonists.
- AVN-101 wikiPageWikiLink Category:Anxiolytics.
- AVN-101 wikiPageWikiLink Category:Nootropics.
- AVN-101 wikiPageWikiLink Clinical_trial.
- AVN-101 wikiPageWikiLink Latrepirdine.
- AVN-101 wikiPageWikiLink Phases_of_clinical_research.
- AVN-101 wikiPageWikiLink Receptor_antagonist.
- AVN-101 wikiPageWikiLink Structural_analog.
- AVN-101 wikiPageWikiLinkText "AVN-101".
- AVN-101 wikiPageUsesTemplate Template:Antidementia.
- AVN-101 wikiPageUsesTemplate Template:Drugbox.
- AVN-101 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- AVN-101 wikiPageUsesTemplate Template:Nootropics.
- AVN-101 wikiPageUsesTemplate Template:Reflist.
- AVN-101 wikiPageUsesTemplate Template:Serotonergics.
- AVN-101 subject Category:5-HT6_antagonists.
- AVN-101 subject Category:Anxiolytics.
- AVN-101 subject Category:Nootropics.
- AVN-101 hypernym Antagonist.
- AVN-101 type ChemicalSubstance.
- AVN-101 type Drug.
- AVN-101 type ChemicalObject.
- AVN-101 type Thing.
- AVN-101 type Q8386.
- AVN-101 comment "AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.".
- AVN-101 label "AVN-101".
- AVN-101 sameAs Q20707794.
- AVN-101 sameAs m.013dbzq9.
- AVN-101 sameAs Q20707794.
- AVN-101 wasDerivedFrom AVN-101?oldid=698190712.
- AVN-101 isPrimaryTopicOf AVN-101.